Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation
ConclusionsThis study suggests that UFH and bivalirudin are associated with similar rates of thrombosis, major bleeding, and mortality events in patients supported by ECMO. However, it was observed that bivalirudin consistently maintained aPTT within the therapeutic range in comparison to UFH.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Haya Kaseer,
Matthew Soto ‐Arenall,
Devang Sanghavi,
John Moss,
Robert Ratzlaff,
Si Pham,
Pramod Guru Tags: ORIGINAL ARTICLE Source Type: research
More News: Angiomax | Bleeding | Cardiovascular & Thoracic Surgery | Hematology | Statistics | Study | Thrombocytopenia | Thrombosis